Using Epinomics’ technology and analytics platform, researchers in pharmaceutical / biotech industry and academia have begun to advance therapeutic development efforts, discovering biomarkers for use in clinical research and advancing immuno-oncology applications. This is enabling the development of more effective therapeutic strategies and improved outcomes for clinical trials and beyond.

Epinomics’​ vision is to create a comprehensive map of human health states, and leverage epigenomics technology and deep analytics to develop a GPS to guide personalized health.